Search results
Results from the WOW.Com Content Network
In adult outpatients with moderate to severe ulcerative colitis, the AGA recommends using infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, or ustekinumab over no treatment. (Strong recommendation, moderate quality evidence)
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology.
This document presents the official recommendations of the American Gastroenterological Association (AGA) on the management of mild-to-moderate ulcerative colitis (UC). The guideline was developed by the AGA Institute’s Clinical Guidelines Committee and approved by the AGA Institute Governing Board.
Society guideline links: Ulcerative colitis in adults; Surgical management of ulcerative colitis; Surveillance and management of dysplasia in patients with inflammatory bowel disease; Treatment of Crohn disease in adults: Dosing and monitoring of tumor necrosis factor-alpha inhibitors; Treatment of psoriatic arthritis
The guideline provides best practices for managing patients with mild-to-moderate ulcerative colitis (UC), focusing on use of both oral and topical 5-aminosalicylates (5-ASA) medications, rectal corticosteroids and oral budesonide.
In October 2020 and January 2021, a group of clinical experts in the field of inflammatory bowel disease (IBD) convened virtually to discuss current ulcerative colitis (UC) guidelines and how to interpret them in the context of the evolving treatment paradigms and targets for UC.
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology.
gly performed using minimally invasive techniques.7–10 This guideline focuses on the surgical man-agement of medically refractory UC and UC-associated colorectal neoplasia, key technical aspects of operative inter-vention, postoperative considerations specific to patients with UC, and emerging concepts in UC that warrant further exploration and ...
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology. 2020 Apr;158 (5):1450-1461. doi: 10.1053/j.gastro.2020.01.006. Epub 2020 Jan 13. Authors.
Ulcerative colitis treatment usually involves either medication therapy or surgery. Several categories of medications may be effective in treating ulcerative colitis. The type you take will depend on the severity of your condition.